PharmacyCodes



N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine en es it fr

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Brand names, N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Analogs

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Brand Names Mixture

  • No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Chemical_Formula

C29H26N4O4Cl1F1S1

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine RX_link

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine fda sheet

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine msds (material safety sheet)

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Synthesis Reference

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Molecular Weight

581.060 g/mol

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Melting Point

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine H2O Solubility

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine State

Solid

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine LogP

2.79

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Dosage Forms

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Indication

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Pharmacology

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Absorption

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine side effects and Toxicity

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Patient Information

No information avaliable

N-{3-Chloro-4-[(3-Fluorobenzyl)Oxy]Phenyl}-6-[5-({[2-(Methylsulfonyl)Ethyl]Amino}Methyl)-2-Furyl]-4-Quinazolinamine Organisms Affected

No information avaliable